FDA Inspection 1219105 — Mission Pharmacal Company
The FDA completed an inspection of Mission Pharmacal Company on June 27, 2023 in Boerne, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Food/Cosmetics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- June 27, 2023
- Fiscal Year
- 2023
- Product Type
- Food/Cosmetics
- Project Area
- Food Composition, Standards, Labeling and Econ
- Location
- Boerne, TX (United States)